Home > Insider Trading > Filing (0001209191-16-128681)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1142596	Nuvasive Inc	NUVA	Surgical & Medical Instruments & Apparatus (3841)	330768598

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1330401	Jason Hannon	7475 Lusk Blvd San Diego CA 92121	Evp, International	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-06-15	2,231	$26.62	37,616	No	4	M	Direct
Common Stock	Acquisiton	2016-06-15	47,769	$26.62	85,385	No	4	M	Direct
Common Stock	Disposition	2016-06-15	35,466	$57.69	49,919	No	4	F	Direct
Common Stock	Disposition	2016-06-15	2,231	$58.42	47,688	No	4	S	Direct
Common Stock	Disposition	2016-06-16	12,303	$57.42	35,385	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2016-06-15	2,231	$0.00	2,231	$26.62
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2016-06-15	47,769	$0.00	47,769	$26.62

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-01-03	No	4	M	Direct
0		2021-01-03	No	4	M	Direct

Footnotes

Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 505 shares acquired under the Issuer's employee stock purchase plan in April 2016.
Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
Sales effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
Weighted average sales price from sales transactions ranging from $57.19 to $57.81. Upon request by the Commission staff or a security holder of the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
The option, representing a right to purchase a total of 2,231 shares, was granted on January 3, 2011 and is fully vested.
The option, representing a right to purchase a total of 47,769 shares, was granted on January 3, 2011 and is fully vested.